Sarah Schneider

10PUBLICATIONS
132CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursHaematologyRegenerative medicine (incl. stem cells)Food properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 16, 2026
Microbiota and immune-related adverse events in cancer immunotherapy.

|Feb 09, 2026
Antigen presentation requirements for effective cDC1-based cancer immunotherapy.

Josué E Pineda, Tomoyuki Minowa, Li Shen

|Oct 22, 2024
The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia.

Ronghua Zhang, Priyanka Khare, Priyanka Banerjee

|Mar 12, 2024
STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response.

Bhakti Patel, Yifan Zhou, Rachel L Babcock

|Nov 11, 2022
Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration.

Yifan Zhou, Yusra B Medik, Bhakti Patel

|Apr 28, 2022
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.

Irene Ganan-Gomez, Hui Yang, Feiyang Ma

Pageof 2

Frequent Collaborators

5 joint publications

Stephanie S Watowich

4 joint publications

Simona Colla

3 joint publications

Feiyang Ma

3 joint publications

Caleb Class